When a TV doctor and a wellness guru announce a healthcare advisory panel, the question isn't what they'll recommend — it's what the whole exercise actually means.
On March 26, the Department of Health and Human Services and the Centers for Medicare & Medicaid Services announced the formation of the Healthcare Advisory Committee — eighteen carefully selected experts convened to advise the administration on how to modernize American medicine. The press release was crisp and optimistic. The committee's mandate was sweeping: chronic disease prevention, Medicare Advantage sustainability, real-time data infrastructure, Medicaid accountability. The language spoke of transformation. Of a system finally pivoting from reactive treatment to genuine prevention.
It was the kind of announcement that, in a different political moment, might have been unremarkable. But nothing about this administration's approach to healthcare is unremarkable.
The committee will report to two men whose presence in American healthcare remains, to put it charitably, a subject of debate.
Dr. Mehmet Oz was confirmed as CMS Administrator in April 2025, along party lines, by a vote of 53 to 45. His path to one of the most consequential regulatory positions in American medicine — overseeing programs that cover roughly half the U.S. population — ran directly through daytime television, a failed Pennsylvania Senate campaign, and years of promoting supplements that federal regulators had repeatedly questioned. During his first all-staff meeting at CMS, Oz praised Secretary Kennedy's Make America Healthy Again initiative and called for replacing human physicians with artificial intelligence models. Since then, he has given Immigration and Customs Enforcement access to the personal data of over 79 million Medicaid enrollees and faced a civil rights complaint from California Governor Gavin Newsom, who accused him of discriminating against Armenians in a video alleging large-scale healthcare fraud in Los Angeles.
A Georgetown University fact-check in February 2026 found that Oz made two factually incorrect statements in a single short video about rural health — overstating the rural-urban life expectancy gap and misrepresenting the scale of a federal investment fund. The pattern is not one of isolated error. It is one of a regulator who arrived at his position through political appointment, not professional consensus — and who governs accordingly.
HHS Secretary Robert F. Kennedy Jr., to whom the committee also reports, brings his own complications. His long-standing skepticism of vaccines, his unconventional views on chronic disease causation, and his "Make America Healthy Again" framework — which blames processed food, environmental toxins, and pharmaceutical industry influence for much of the country's health burden — have made him simultaneously popular with a segment of the public and deeply alarming to mainstream public health institutions. His framing of the committee's purpose as moving from a "sick care system" to a "health care system" is rhetorically compelling. It also happens to describe a goal that virtually every healthcare reformer of the last fifty years has claimed.
Then there is the committee itself.
The roster includes physicians, lawyers, health system executives, and policy veterans. Several names carry genuine credibility. But the most discussed appointment is the one that requires the least introduction: Tony Robbins, the motivational speaker and entrepreneur whose seminars on peak
performance have made him a cultural institution, and whose connection to the mechanics of Medicare reimbursement or Medicaid oversight is not immediately apparent.
His inclusion is either a sign that the administration is serious about thinking differently about health — bringing in voices from wellness, behavior change, and human motivation — or it is a signal that the committee is more interested in aesthetics than in actuarial rigor. Both interpretations are worth holding simultaneously.
It is also worth noting that the committee's recommendations will be non-binding. The panel will advise. It will not legislate, regulate, or allocate. Whatever wisdom its members produce will flow upward to Oz and Kennedy, who will decide what, if anything, to do with it. In Washington, advisory committees are sometimes vehicles for genuine policy development. More often, they are a way of demonstrating that a conversation is happening without committing to where it leads.
The administration's actual healthcare record, running in parallel with this announcement, tells a different story than the language of transformation suggests.
ACA marketplace enrollment had reached 24.3 million in 2025, a historic high, built substantially on enhanced tax credits that were allowed to expire entering 2026. The administration has threatened Medicaid funding to multiple states, wielding federal dollars as leverage in disputes over state program administration. The gap between the committee's stated priorities — better chronic disease management, stronger care for vulnerable populations — and the policy environment in which those priorities are supposed to be pursued is not small.
This is the essential tension in the Healthcare Advisory Committee announcement. The goals it articulates are not controversial. Nobody argues for worse chronic disease management or less accountability in patient outcomes. The question is whether a panel reporting to these particular leaders, in this particular political context, is genuinely intended to produce recommendations that will be implemented — or whether it is intended to produce a rhetorical position: that this administration takes healthcare seriously, thinks boldly, and has assembled the people to prove it.
American healthcare is, by nearly every measure, broken in ways that are expensive, painful, and deeply politically inconvenient to fix. It costs more than any comparable nation and produces worse outcomes. Its administrative burden is grotesque. Its relationship to chronic disease — the primary driver of both mortality and cost — is one of management rather than prevention.
A committee cannot fix any of this. But it can signal intent, shift conversation, and, occasionally, produce ideas that find their way into policy years later. The Healthcare Advisory Committee might do some or all of that. It might also hold a few meetings, publish some non-binding recommendations, and quietly dissolve.
What is certain is that the announcement was received, processed, and filed — by the public, by the industry, and by the 400-plus people who submitted nominations and didn't make the cut — as a statement about who this administration trusts to think about American healthcare.
Tony Robbins made that list. Many of the country's leading epidemiologists did not.
That is its own kind of answer.
Sources
1. CMS Press Release — HHS and CMS Announce Healthcare Advisory Committee Members, March 26, 2026. cms.gov
2. Wikipedia — Mehmet Oz. en.wikipedia.org
3. Georgetown CCF — Fact-Checking Dr. Oz' Claims About Rural Health Investments, February 6, 2026. ccf.georgetown.edu
4. STAT News — Newsom Files Civil Rights Complaint Against CMS' Oz, January 30, 2026. statnews.com
5. Minnesota Reformer — What's Going On with Minnesota Medicaid Funding?, March 23, 2026. minnesotareformer.com
6. Rep. Krishnamoorthi Press Release — Krishnamoorthi Warns CMS Administrator Dr. Oz, October 17, 2025. krishnamoorthi.house.gov
7. NBC News — Senate Confirms Mehmet Oz for Top CMS Post, April 3, 2025. nbcnews.com
